AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
MEGESTROL-ACETATE PLUS ALPHA-2A-INTERFERON AS 2ND LINE THERAPY FOR POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC PHASE-II TRIAL
Authors: AMOROSO D BOCCARDO F BALESTRERO M MIGLIETTA L BREMA F CELLERINO R FARRIS A FOLCO U IACOBELLI S MESITI M
Citation: D. Amoroso et al., MEGESTROL-ACETATE PLUS ALPHA-2A-INTERFERON AS 2ND LINE THERAPY FOR POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER - RESULTS OF A MULTICENTRIC PHASE-II TRIAL, Breast cancer research and treatment, 33(3), 1995, pp. 265-268
EXPRESSION OF TUMOR-ASSOCIATED 90K-ANTIGEN IN HUMAN BREAST-CANCER - NO CORRELATION WITH PROGNOSIS AND RESPONSE TO FIRST-LINE THERAPY WITH TAMOXIFEN
Authors: FOEKENS JA KLIJN JGM NATOLI C VANPUTTEN WLJ DISTEFANO P LOOK MP PORTENGEN H IACOBELLI S
Citation: Ja. Foekens et al., EXPRESSION OF TUMOR-ASSOCIATED 90K-ANTIGEN IN HUMAN BREAST-CANCER - NO CORRELATION WITH PROGNOSIS AND RESPONSE TO FIRST-LINE THERAPY WITH TAMOXIFEN, International journal of cancer, 64(2), 1995, pp. 130-134
SUPPRESSION OF TUMOR-GROWTH IN-VIVO BY LOCAL AND SYSTEMIC 90K LEVEL INCREASE
Authors: JALLAL B POWELL J ZACHWIEJA J BRAKEBUSCH C GERMAIN L JACOBS J IACOBELLI S ULLRICH A
Citation: B. Jallal et al., SUPPRESSION OF TUMOR-GROWTH IN-VIVO BY LOCAL AND SYSTEMIC 90K LEVEL INCREASE, Cancer research, 55(15), 1995, pp. 3223-3227
PANCREATIC-JUICE 90K AND SERUM CA-19-9 COMBINED DETERMINATION CAN DISCRIMINATE BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS
Authors: GENTILONI N CARADONNA P COSTAMAGNA G DOSTILIO N PERRI V MUTIGNANI M FEBBRARO S TINARI N IACOBELLI S NATOLI C
Citation: N. Gentiloni et al., PANCREATIC-JUICE 90K AND SERUM CA-19-9 COMBINED DETERMINATION CAN DISCRIMINATE BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS, The American journal of gastroenterology, 90(7), 1995, pp. 1069-1072
CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL
Authors: LEVI FA ZIDANI R VANNETZEL JM PERPOINT B FOCAN C FAGGIUOLO R CHOLLET P GARUFI C ITZHAKI M DOGLIOTTI L IACOBELLI S ADAM R KUNSTLINGER F GASTIABURU J BISMUTH H JASMIN C MISSET JL
Citation: Fa. Levi et al., CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL, Journal of the National Cancer Institute, 86(21), 1994, pp. 1608-1617
CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL
Authors: LEVI FA ZIDANI R VANNETZEL JM PERPOINT B FOCAN C FAGGIUOLO R CHOLLET P GARUFI C ITZHAKI M DOGLIOTTI L IACOBELLI S ADAM R KUNSTLINGER F GASTIABURU J BISMUTH H JASMIN C MISSET JL
Citation: Fa. Levi et al., CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL, Journal of the National Cancer Institute, 86(21), 1994, pp. 1608-1617
90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS
Authors: REA A PALMIERI G TINARI N NATOLI C TAGLIAFERRI P MORABITO A GRASSADONIA A BIANCO AR IACOBELLI S
Citation: A. Rea et al., 90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS, Oncology Reports, 1(4), 1994, pp. 723-725
POSITIVE BEHAVIORAL SUPPORT FOR STUDENTS WITH SEVERE DISABILITIES - AN EMERGING MULTICOMPONENT APPROACH FOR ADDRESSING CHALLENGING BEHAVIORS
Authors: BAMBARA LM MITCHELLKVACKY NA IACOBELLI S
Citation: Lm. Bambara et al., POSITIVE BEHAVIORAL SUPPORT FOR STUDENTS WITH SEVERE DISABILITIES - AN EMERGING MULTICOMPONENT APPROACH FOR ADDRESSING CHALLENGING BEHAVIORS, School psychology review, 23(2), 1994, pp. 263-278
CARBOPLATIN, EPIRUBICIN, AND VP-16 CHEMOTHERAPY IN THE TREATMENT OF SMALL-CELL LUNG-CANCER
Authors: GRIDELLI C IANNIELLO GP MAIORINO A CURCIO C DAPRILE M BRANCACCIO L PALMERI S GENTILE M COMELLA G PEDICINI T AIROMA G VELTRI E GEBBIA V RUSSO A CASARETTI R GIAMPAGLIA F FERRANTE G RAUSA L IACOBELLI S ARCANGELI G DEPLACIDO S BIANCO AR
Citation: C. Gridelli et al., CARBOPLATIN, EPIRUBICIN, AND VP-16 CHEMOTHERAPY IN THE TREATMENT OF SMALL-CELL LUNG-CANCER, American journal of clinical oncology, 17(2), 1994, pp. 160-167
ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)
Authors: NATOLI C ORTONA L TAMBURRINI E TINARI N DISTEFANO P DEGIDIO M GHINELLI F SIGHINOLFI L DOSTILIO N PIAZZA M GRASSADONIA A IACOBELLI D IACOBELLI S
Citation: C. Natoli et al., ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV), Anticancer research, 14(3B), 1994, pp. 1457-1460
RELATIONSHIP BETWEEN THE TUMOR-ASSOCIATED ANTIGEN-90K AND CYTOKINES IN THE CIRCULATION OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: SENALDI G PEAKMAN M NATOLI C HUSSAIN MJ GALLATI H MCMANUS T VERGANI D IACOBELLI S
Citation: G. Senaldi et al., RELATIONSHIP BETWEEN THE TUMOR-ASSOCIATED ANTIGEN-90K AND CYTOKINES IN THE CIRCULATION OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infection, 28(1), 1994, pp. 31-39
BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF THE CYCLOOXYGENASE ACTIVITY OF HUMAN BLOOD PROSTAGLANDIN ENDOPEROXIDE SYNTHASES
Authors: PATRIGNANI P PANARA MR GRECO A FUSCO O NATOLI C IACOBELLI S CIPOLLONE F GANCI A CREMINON C MACLOUF J PATRONO C
Citation: P. Patrignani et al., BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF THE CYCLOOXYGENASE ACTIVITY OF HUMAN BLOOD PROSTAGLANDIN ENDOPEROXIDE SYNTHASES, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1705-1712
THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR
Authors: ULLRICH A SURES I DEGIDIO M JALLAL B POWELL TJ HERBST R DREPS A AZAM M RUBINSTEIN M NATOLI C SHAWVER LK SCHLESSINGER J IACOBELLI S
Citation: A. Ullrich et al., THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR, The Journal of biological chemistry, 269(28), 1994, pp. 18401-18407
EFFECTS OF TYPE-I AND TYPE-II INTERFERONS ON 90K ANTIGEN EXPRESSION IN OVARIAN-CARCINOMA CELLS
Authors: MARTH C DREPS A NATOLI C ZEIMET AG LANG T WIDSCHWENDTER M DAXENBICHLER G ULLRICH A IACOBELLI S
Citation: C. Marth et al., EFFECTS OF TYPE-I AND TYPE-II INTERFERONS ON 90K ANTIGEN EXPRESSION IN OVARIAN-CARCINOMA CELLS, International journal of cancer, 59(6), 1994, pp. 808-813
BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF THE CYCLOOXYGENASE ACTIVITY OF HUMAN BLOOD PROSTAGLANDIN ENDOPEROXIDE SYNTHASES
Authors: PATRIGNANI P PANARA MR GRECO A FUSCO O NATOLI C IACOBELLI S DISIPIO M CIPOLLONE F GANCI A MACLOUF J PATRONO C
Citation: P. Patrignani et al., BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF THE CYCLOOXYGENASE ACTIVITY OF HUMAN BLOOD PROSTAGLANDIN ENDOPEROXIDE SYNTHASES, Clinical research, 42(2), 1994, pp. 10000251-10000251
PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER
Authors: IACOBELLI S SISMONDI P GIAI M DEGIDIO M TINARI N AMATETTI C DISTEFANO P NATOLI C
Citation: S. Iacobelli et al., PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER, British Journal of Cancer, 69(1), 1994, pp. 172-176
EXPRESSION OF HER-2 NEU ONCOPROTEIN, DNA-PLOIDY AND S-PHASE FRACTION IN ADVANCED OVARIAN-CANCER
Authors: SCAMBIA G PANICI PB FERRANDINA G BATTAGLIA F BAIOCCHI G DISTEFANO P TINARI N CORONETTA F PIANTELLI M NATALI P IACOBELLI S MANCUSO S
Citation: G. Scambia et al., EXPRESSION OF HER-2 NEU ONCOPROTEIN, DNA-PLOIDY AND S-PHASE FRACTION IN ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 3(5), 1993, pp. 271-278
LACK OF PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL DETERMINATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN PROSTATE-CANCER
Authors: AMATETTI C ANGELUCCI D FIORENTINO B TINARI N DISTEFANO P TENAGLIA R IACOBELLI S NATOLI C
Citation: C. Amatetti et al., LACK OF PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL DETERMINATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN PROSTATE-CANCER, International journal of oncology, 3(5), 1993, pp. 887-889
A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN
Authors: BRIGGS NC NATOLI C TINARI N DEGIDIO M GOEDERT JJ IACOBELLI S
Citation: Nc. Briggs et al., A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN, AIDS research and human retroviruses, 9(9), 1993, pp. 811-816
PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN HIV-INFECTED HEMOPHILIA PATIENTS
Authors: LONGO G NATOLI C RAFANELLI D TINARI N MORFINI M ROSSIFERRINI P DOSTILIO N IACOBELLI S
Citation: G. Longo et al., PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN HIV-INFECTED HEMOPHILIA PATIENTS, British Journal of Haematology, 85(1), 1993, pp. 207-209
Risultati: 1-25 | 26-45 |